Jan 14 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* THE BOARD OF DIRECTORS OF INDEX PHARMACEUTICALS HOLDING AB
HAS
RESOLVED ON A FULLY GUARANTEED RIGHTS ISSUE OF APPROXIMATELY
MSEK 533
* RESOLVED ON A RIGHTS ISSUE OF APPROXIMATELY 444 MILLION
SHARES
AT A SUBSCRIPTION PRICE OF SEK 1.20 PER SHARE
* AT FULL SUBSCRIPTION IN RIGHTS ISSUE COMPANY WILL RECEIVE
APPROXIMATELY MSEK 533 BEFORE DEDUCTION OF COSTS RELATED TO
TRANSACTION
* INTENTION OF ISSUE IS TO FUND IMPORTANT INITIAL INDUCTION
STUDY
IN A SEQUENTIAL PHASE III PROGRAM FOR CO'S LEAD DRUG CANDIDATE,
COBITOLIMOD
* SUBSCRIPTION PERIOD WILL RUN FROM 22 JANUARY 2021 TO 5
FEBRUARY
2021
Source text for Eikon: ID:nWkrb8dSq
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))